These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30517302)

  • 41. Current evidences on the XPG Asp1104His polymorphism and melanoma susceptibility: a meta-analysis based on case-control studies.
    Xu Y; Jiao G; Wei L; Wang N; Xue Y; Lan J; Wang Y; Liu C; Lou M
    Mol Genet Genomics; 2015 Feb; 290(1):273-9. PubMed ID: 25231183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma.
    Italiano A; Laurand A; Laroche A; Casali P; Sanfilippo R; Le Cesne A; Judson I; Blay JY; Ray-Coquard I; Bui B; Coindre JM; Nieto A; Tercero JC; Jimeno J; Robert J; Pourquier P
    Cancer; 2011 Aug; 117(15):3445-56. PubMed ID: 21287534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between the XPG gene Asp1104His polymorphism and lung cancer risk.
    Zhou B; Hu XM; Wu GY
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of a p73 exon 2 GC/AT polymorphism with colorectal cancer risk and survival in Tunisian patients.
    Arfaoui AT; Kriaa LB; El Hadj Oel A; Ben Hmida MA; Khiari M; Khalfallah T; Gharbi L; Mzabi S; Bouraoui S
    Virchows Arch; 2010 Sep; 457(3):359-68. PubMed ID: 20644956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population.
    Li RJ; Li M; Liu GJ; Guo YW; Bai H; Xiao P; Mei JZ
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of XRCC1 and ERCC5 polymorphisms on clinical outcomes in advanced non-small cell lung cancer.
    Liu D; Wu J; Shi GY; Zhou HF; Yu Y
    Genet Mol Res; 2014 Apr; 13(2):3100-7. PubMed ID: 24782167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer.
    Spindler KG; Andersen RF; Jensen LH; Ploen J; Jakobsen A
    Ann Oncol; 2010 Mar; 21(3):535-539. PubMed ID: 19850635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy.
    Park HA; Seibold P; Edelmann D; Benner A; Canzian F; Alwers E; Jansen L; Schneider M; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):352-361. PubMed ID: 34862210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meta-analysis of the relationship between excision repair cross-complementing Group 5 rs17655 gene polymorphism and head and neck cancer susceptibility.
    Li T; Ling H; Lu Y; Wu X; Cai M; Su B; Zou Y
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1041-S1047. PubMed ID: 30539843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin.
    van Huis-Tanja LH; Kweekel DM; Lu X; Franken K; Koopman M; Gelderblom H; Antonini NF; Punt CJ; Guchelaar HJ; van der Straaten T
    Mutat Res; 2014 Jan; 759():37-44. PubMed ID: 24220697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors.
    Sun XH; Hou WG; Zhao HX; Zhao YL; Ma C; Liu Y
    Asian Pac J Cancer Prev; 2013; 14(3):2049-52. PubMed ID: 23679317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphisms of nucleotide excision repair genes predict melanoma survival.
    Li C; Yin M; Wang LE; Amos CI; Zhu D; Lee JE; Gershenwald JE; Grimm EA; Wei Q
    J Invest Dermatol; 2013 Jul; 133(7):1813-21. PubMed ID: 23407396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer.
    Huang ZH; Hua D; Du X; Li LH; Mao Y; Liu ZH; Song MX; Zhou XK
    World J Gastroenterol; 2008 Nov; 14(41):6401-7. PubMed ID: 19009659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.
    Rouissi K; Bahria IB; Bougatef K; Marrakchi R; Stambouli N; Hamdi K; Cherif M; Ben Slama MR; Sfaxi M; Othman FB; Chebil M; Elgaaied AB; Ouerhani S
    BMC Cancer; 2011 Mar; 11():101. PubMed ID: 21426550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of polymorphisms in ERCC5, XPA and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population.
    Ruiz-Cosano J; Torres-Moreno D; Conesa-Zamora P
    J BUON; 2013; 18(2):486-90. PubMed ID: 23818366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ERCC1 and ERCC2 as predictive biomarkers to oxaliplatin-based chemotherapy in colorectal cancer patients from Egypt.
    Kassem AB; Salem SE; Abdelrahim ME; Said AS; Salahuddin A; Hussein MM; Bahnassy AA
    Exp Mol Pathol; 2017 Feb; 102(1):78-85. PubMed ID: 28088319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder.
    Sakano S; Kumar R; Larsson P; Onelöv E; Adolfsson J; Steineck G; Hemminki K
    BJU Int; 2006 Apr; 97(4):847-51. PubMed ID: 16536785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.
    Stoehlmacher J; Park DJ; Zhang W; Yang D; Groshen S; Zahedy S; Lenz HJ
    Br J Cancer; 2004 Jul; 91(2):344-54. PubMed ID: 15213713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of single nucleotide polymorphisms of nucleotide excision repair genes with laryngeal cancer risk and interaction with cigarette smoking and alcohol drinking.
    Li X; Xu J; Yang X; Wu Y; Cheng B; Chen D; Bai B
    Tumour Biol; 2014 May; 35(5):4659-65. PubMed ID: 24563277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.
    Park DJ; Zhang W; Stoehlmacher J; Tsao-Wei D; Groshen S; Gil J; Yun J; Sones E; Mallik N; Lenz HJ
    Clin Adv Hematol Oncol; 2003 Mar; 1(3):162-6. PubMed ID: 16224397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.